Purpose: This study investigated whether the nonincision placement of miniscrews could lead to ectopic implantation of epithelium at the bone-implant interface and, if so, whether the epithelial cells could survive. The fate of grafted epithelial cells was also investigated.
Materials And Methods: Ten healthy male beagle dogs were included in the study and were divided into three groups. Group 1 dogs (n = 3) were implanted with miniscrews without any other procedures. In group 2, epithelial cells were collected, infected by adeno-associated virus-2 containing green fluorescent protein (GFP), and injected into pilot holes drilled before miniscrew implantation in three dogs, and one dog was injected with epithelial cells as a negative control. In group 3, tiny gingival tissue pieces were injected into pilot holes drilled before miniscrew implantation. In group 1, hematoxylin-eosin and fluorescent immunohistochemical (IHC) staining of cytokeratin were performed on both undecalcified and decalcified slices. In groups 2 and 3, IHC staining of cytokeratin and apoptotic testing were performed.
Results: No ectopically implanted epithelial cells were found at the bone-implant interface of the miniscrews in group 1. In group 2, fluorescence emitted by cytokeratin antibody and by GFP was observed in specimens at 0 days, had decreased by 3 days, and had disappeared by 7 days. In group 3, areas of fluorescent cytokeratin-positive tissues were much smaller at 7 days than at 0 days, and none were found at 28 days. In groups 2 and 3, there were many apoptotic epithelial cells at the bone-implant interface at 3 days and 7 days, respectively.
Conclusion: There was little possibility of implantation of epithelium into alveolar bone though placement of miniscrews with a nonincision procedure. Furthermore, even when epithelial cells or tissue was ectopically implanted, it was soon cleared through an apoptotic process.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.11607/jomi.3456 | DOI Listing |
Otolaryngol Head Neck Surg
January 2025
Department of Otolaryngology-Head and Neck Surgery, University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama, USA.
Objective: Cystic fibrosis (CF) is a clinical entity defined by aberrant chloride (Cl) ion transport causing downstream effects on mucociliary clearance (MCC) in sinonasal epithelia. Inducible deficiencies in transepithelial Cl transport via CF transmembrane conductance regulator (CFTR) has been theorized to be a driving process in recalcitrant chronic rhinosinusitis (CRS) in patients without CF. We have previously identified that brief exposures to bacterial lipopolysaccharide (LPS) in mammalian cells induces an acquired dysfunction of CFTR in vitro and in vivo.
View Article and Find Full Text PDFBiotechnol J
January 2025
Department of Biological Sciences, KAIST, Daejeon, Republic of Korea.
Increasing demand for adeno-associated virus (AAV) used in gene therapy highlights the need to enhance AAV production. When intracellular AAV2 and extracellular AAV9 were produced in HEK293T cells using the triple transfection method, apoptosis occurred during the AAV production. To mitigate apoptosis induced by AAV production, the pro-apoptotic BAX/BAK1 genes were knocked out in HEK293T cells.
View Article and Find Full Text PDFIUBMB Life
January 2025
Department of Reproductive Medical Center, First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China.
Abnormality of granulosa cells (GCs) is the critical cause of follicular atresia in premature ovarian failure (POF). RIPK3 is highly expressed in GCs derived from atretic follicles. We focus on uncovering how RIPK3 contributes to ovarian GC senescence.
View Article and Find Full Text PDFStem Cell Res Ther
January 2025
Department of Medicine, Veterans Affairs Medical Center, Washington, DC, USA.
Introduction: Effects of Dapagliflozin (Dapa) and Dapagliflozin-Saxagliptin combination (Combo) was examined on peripheral blood derived CD34 + Hematopoetic Stem Cells (HSCs) as a cellular CVD biomarker. Both Dapa (a sodium-glucose co-transporter 2 or SGLT2, receptor inhibitor) and Saxagliptin (a Di-peptydl-peptidase-4 or DPP4 enzyme inhibitor) are commonly used type 2 diabetes mellitus or T2DM medications, however the benefit of using the combination has not been evaluated for cardio-renal risk assessment, in a real-life practice setting, compared to a placebo.
Hypothesis: We hypothesized that Dapa will improve the outcomes when compared to placebo and the Combo maybe even more beneficial.
Stem Cell Res Ther
January 2025
Applied Oral Sciences and Community Dental Care, Faculty of Dentistry, Prince Philip Dental Hospital, The University of Hong Kong, 34 Hospital Road, Sai Ying Pun, Hong Kong, Hong Kong SAR.
Background: Achieving a stable vasculature is crucial for tissue regeneration. Endothelial cells initiate vascular morphogenesis, followed by mural cells that stabilize new vessels. This study investigated the in vivo effects of Sema4D-Plexin-B1 signaling on stem cells from human exfoliated deciduous teeth (SHED)-supported angiogenesis, focusing on its mechanism in PDGF-BB secretion.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!